PacificHealth Laboratories, Inc.
PHLI
OTC PK
| Weiss Ratings | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -133.24 | |||
| Price History | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Feb 12, 2025 | |||
| 52-Week High Price (Date) | Feb 12, 2025 | |||
| Valuation | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877-363-8769 | |||
| Address | 100 Matawan Road Matawan, NJ 07747 | |||
| Website | www.pacifichealthlabs.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -13.90% | |||
| Profit Margin | -14.15% | |||
| Management Effectiveness | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -24.61% | |||
| Return on Equity | -- | |||
| Income Statement | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.67M | |||
| Total Revenue (TTM) | 6.67M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 2.57M | |||
| EBITDA (TTM) | -861.60K | |||
| EBIT (TTM) | -927.20K | |||
| Net Income (TTM) | -943.50K | |||
| Net Income Avl. to Common (TTM) | -943.50K | |||
| Total Revenue Growth (Q YOY) | -12.71% | |||
| Earnings Growth (Q YOY) | -195.97% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | -100.00% | |||
| Balance Sheet | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 324.50K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 1.84M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 827.10K | |||
| Current Ratio (Q) | 1.580 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 1.17M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 827.10K | |||
| Cash Flow | PHLI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -153.80K | |||
| Cash from Financing (TTM) | -22.00K | |||
| Net Change in Cash (TTM) | -765.30K | |||
| Levered Free Cash Flow (TTM) | -415.00K | |||
| Cash from Operations (TTM) | -589.50K | |||
